Combilytics is a biotechnology company specializing in the creation of natural senolytic solutions that bolster anti-aging functions.
Combilytics has raised $250K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2022.
Combilytics's investors include Newchip Accelerator.
Combilytics is headquartered in London, Canada.
Combilytics is a biotechnology company specializing in the creation of natural senolytic solutions that bolster anti-aging functions.
Combilytics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Combilytics — Funding & Investors." VCBacked, April 28, 2022, https://www.vcbacked.co/company/combilytics. Accessed July 25, 2026.
VCBacked. (2022). Combilytics — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/combilytics
{{cite web |title=Combilytics — Funding & Investors |url=https://www.vcbacked.co/company/combilytics |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated